Reproductive Genetics Market to Grow with a CAGR of 13.52% through 2030
Increasing
demand for genetic testing and screening is expected to drive the growth of
global reproductive genetics market in the forecast period, 2026-2030.
According
to TechSci Research report, “Reproductive Genetics Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, the Global
Reproductive Genetics Market was valued at USD 5.87 billion in 2024 and is
expected to reach USD 12.56 billion by 2030 with a CAGR of 13.52% during the
forecast period. This can be ascribed to the increasing
demand for genetic testing and screening to identify genetic disorders among
the global population. Additionally, growing maternal age leading to pregnancy
complications, especially in the developed countries in the North America and
Europe, is expected to create lucrative opportunities for the market growth in
the coming years. Besides, increasing demand for early detection and prevention
of genetic disorder is further expected to support the market growth. Similarly,
rising maternal age leads to pregnancy complications, and rising emphasis on
early detection and prevention will further boost the market growth during the
forecast period. Also, rising funding opportunities for testing instruments,
shifting of reimbursement policies toward enhanced genetic testing coverage
will drive the market growth over the years.
However, the lack of awareness on genetic disorders and high cost of
genetic testing is slowing down the growth of global reproductive genetics market
in the forecast period. Similarly, low economical conditions in the
underdeveloped regions along with the lack of favorable insurance systems, may
hamper the reproductive genetics market growth during the
forecast period. Also, lack of social acceptance due to negative impacts of
genetic testing in emerging countries, can further restrict the growth of
global reproductive genetics market. Similarly, lack of
regulations about genetic testing may hamper the growth of the market.
The Global Reproductive Genetics Market is
segmented into component, technology, procedure type, application, regional
distribution, and company.
Based on Technology, Next Generation Sequencing (NGS) is the
technology category showing the fastest growth. This rapid expansion is being
driven by NGS's ability to deliver high-throughput, cost-effective, and
comprehensive genetic analysis, making it particularly valuable for a wide
range of reproductive applications such as non-invasive prenatal testing
(NIPT), carrier screening, preimplantation genetic testing (PGT), and newborn
screening. NGS offers significant advantages over traditional techniques like
PCR and microarrays. It enables simultaneous analysis of thousands of genes or
even entire genomes, which enhances diagnostic accuracy and increases the
probability of identifying pathogenic variants. For instance, in
preimplantation genetic testing for aneuploidy (PGT-A), NGS can detect
chromosomal abnormalities more precisely than older fluorescence in situ
hybridization (FISH) methods. In prenatal care, NGS has been integral to the
growth of NIPT, which analyzes cell-free fetal DNA with remarkable sensitivity
and specificity.
Based on the Region, Asia Pacific is emerging as the
fastest-growing region in the global reproductive genetics market, driven by a
combination of rising fertility awareness, increasing healthcare expenditure,
and improving access to genetic testing technologies. Countries like China,
India, Japan, and South Korea are leading this growth, with expanding
healthcare infrastructure and a growing emphasis on advanced maternal care and
personalized medicine. The region's rapid population growth, coupled with increasing
incidences of genetic disorders and delayed pregnancies, has heightened demand
for reproductive genetic testing. In India, for instance, the government’s
initiatives like the Ayushman Bharat scheme and growing private sector
investment in fertility clinics have improved access to preimplantation genetic
testing (PGT) and non-invasive prenatal testing (NIPT). Meanwhile, China’s
relaxation of its one-child policy has led to an increase in pregnancies among
older women, further contributing to the demand for prenatal genetic screening.
Major
companies operating in the Global Reproductive Genetics Market are:
- CooperSurgical,
Inc.
- Centogene
AG
- Invitae
Corporation
- Illumina,
Inc.
- Myriad
Genetics, Inc.
- Thermo
Fisher Scientific Inc.
- Laboratory
Corporation of America Holdings
- Quest
Diagnostics
- Natera,
Inc
- Eurofins
Scientific SE
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“North
America is expected to dominate in the global reproductive genetics market due to
the increasing number of invitro fertilization procedures among people across
the region. Furthermore, the increasing adoption of advance genomic techniques
to identify genetic disorders, along with the increasing demand for using
advanced techniques in developing regions are further contributing to demand
for reproductive genetics. Also, growing demand for needful information about
the probability of having a child or not will further boost the market growth
during the forecast period. Besides, increasing favorable government
reimbursement policies and growing awareness about genome sequencing in the
region are further expected to create lucrative opportunities for the market
growth” said Mr. Karan Chechi, Research Director of TechSci Research, a
research based global management consulting firm.
“Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays), By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing), By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global reproductive genetics market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global reproductive genetics market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com